Design and optimization of (3-aryl-1H-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-ones as potent PLK4 inhibitors with oral antitumor efficacy

Autor: Li, Sze-Wan, Liu, Yong, Sampson, Peter B., Patel, Narendra Kumar, Forrest, Bryan T., Edwards, Louise, Laufer, Radoslaw, Feher, Miklos, Ban, Fuqiang, Awrey, Donald E., Hodgson, Richard, Beletskaya, Irina, Mao, Guodong, Mason, Jacqueline M., Wei, Xin, Luo, Xunyi, Kiarash, Reza, Green, Erin, Mak, Tak W., Pan, Guohua, Pauls, Henry W.
Zdroj: In Bioorganic & Medicinal Chemistry Letters 1 October 2016 26(19):4625-4630
Databáze: ScienceDirect